Guardian Pharmacy Services, Inc.
GRDNHealthcareNASDAQMedical Care Facilities
Scan Results
Daily timeframeGuardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. At a $2.45B market cap, Guardian Pharmacy Services, Inc. ranks as a mid-cap company within healthcare. The company's individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities, behavioral health facilities, and group homes.
Market Cap
$2.45B
Beta
—
P/E (TTM)
46.12
P/E (Fwd)
28.52
EPS (TTM)
$0.84
EPS (Fwd)
$1.36
ROE
26.9%
ROA
14.4%
Cash
$64.9M
Total Debt
$41.2M
Free CF
$67.0M
52W Change
82.0%
Annual Financials
Cash vs Debt
Guardian Pharmacy Services, Inc. holds $64.9M in cash against $41.2M in total debt, giving it a net cash position. This means the company could theoretically pay off all its debt and still have cash remaining. Free cash flow comes in at $67.0M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. Return on equity stands at 26.9%, which is strong for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Return on assets of 14.4% further supports the picture of efficient asset utilization. Revenue has grown from $908.9M (2022) to $1.45B (2025), reflecting a 59% increase over the period.
Investors considering Guardian Pharmacy Services, Inc. should weigh the typical risks associated with GRDN's sector, size, and financial profile against their own risk tolerance and investment objectives. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Guardian Pharmacy Services, Inc. and its sector.